The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
about
A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.Botulinum toxin in poststroke spasticityOnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Immunogenicity of botulinum toxins.Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients.Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.Successive motor nerve blocks to identify the muscles causing a spasticity pattern: example of the arm flexion pattern.Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.Rasch measurement: the Arm Activity measure (ArmA) passive function sub-scale.Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatmentTreatment of Upper Limb Spasticity after Stroke: One-Year Safety and Efficacy of Botulinum Toxin Type A NT201The Effect of Repeated Botulinum Toxin A Therapy Combined with Intensive Rehabilitation on Lower Limb Spasticity in Post-Stroke Patients
P2860
Q34611482-39E868E1-DF51-4E64-B315-8533C34E9CF7Q36868342-51A2FA77-A833-4816-A65E-7E6A6EC94310Q37678415-A4C35E09-7FB5-40B6-9E0A-554865A39EAAQ37737039-92B2594D-4CCB-4AFD-9A7B-2FFB837C9943Q37888668-0F3BDEFA-CEBA-491D-99A0-69E4D6DDB0E7Q38046142-F2A1CCFB-2338-4ABC-85C4-12D43278CE88Q44608563-BC098986-0DC2-4188-ACC4-AD2BD9442E7EQ47107133-C9212B17-71A9-4C28-88CD-EB269C79549AQ47391688-923343B7-70A1-494E-AE4F-417175871E4CQ48155657-373AC6D0-F1E0-4E43-9460-163CD13754B0Q53171571-A79A9FA7-61D2-4E0F-AB5F-6D88C48EC83BQ57466784-A61EE8C8-E1AA-4209-8892-6EEF7D1B3F2AQ58005732-762C84A9-129E-47DB-8FDC-25E8015EEB2EQ58779275-24DBCD48-1CFC-4FAF-B6C3-BDE6A2E34381
P2860
The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The beneficial antispasticity ...... ter repeated treatment cycles.
@ast
The beneficial antispasticity ...... ter repeated treatment cycles.
@en
type
label
The beneficial antispasticity ...... ter repeated treatment cycles.
@ast
The beneficial antispasticity ...... ter repeated treatment cycles.
@en
prefLabel
The beneficial antispasticity ...... ter repeated treatment cycles.
@ast
The beneficial antispasticity ...... ter repeated treatment cycles.
@en
P2093
P2860
P356
P1476
The beneficial antispasticity ...... ter repeated treatment cycles.
@en
P2093
Bakheit AM
Fedorova NV
Skoromets AA
Timerbaeva SL
P2860
P304
P356
10.1136/JNNP.2003.035139
P407
P577
2004-11-01T00:00:00Z